bamlanivimab: Clinical Trials

3 trials of bamlanivimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Terminated 2, Unknown 1

Follow bamlanivimab: new trials by email Literature Review of bamlanivimab trials Research Report on bamlanivimab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19
Bamlanivimab, Standard of Care - Covid19
Phase 4UnknownFraser Health5762021-03-172021-08-26
Treatment of Nosocomial COVID-19
Anti-SARS-CoV-2 mAb - Covid19, Nosocomial Infection
Phase 4TerminatedUniversity of Calgary462021-02-122023-04-19
At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19
bamlanivimab - Covid19
Phase 4TerminatedDaniel Griffin1392021-01-042022-03-18

Conditions studied

COVID-19 (3)  ·  Cross Infection (1)

Sponsors

Daniel Griffin (1)  ·  Fraser Health (1)  ·  University of Calgary (1)

Countries

Canada (2)  ·  United States (1)

Top investigators

Alain Tremblay (1)  ·  Dan Griffin, MD, PHD (1)  ·  Robert Fowler (1)  ·  Srinivas Murthy (1)

Results publications

PMID 34473343